Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety 'Mode of Action' framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology.
© The Author 2015. Published by Oxford University Press.
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S184-202. doi: 10.1093/carcin/bgv036. Carcinogenesis. 2015. PMID: 26106137 Free PMC article. Review.
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S89-110. doi: 10.1093/carcin/bgv032. Carcinogenesis. 2015. PMID: 26106145 Free PMC article. Review.
Causes of genome instability: the effect of low dose chemical exposures in modern society.Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S61-88. doi: 10.1093/carcin/bgv031. Carcinogenesis. 2015. PMID: 26106144 Free PMC article. Review.
The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S38-60. doi: 10.1093/carcin/bgv030. Carcinogenesis. 2015. PMID: 26106143 Free PMC article. Review.
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S203-31. doi: 10.1093/carcin/bgv037. Carcinogenesis. 2015. PMID: 26106140 Free PMC article. Review.
Cited by 54 articles
Novel application of normalized pointwise mutual information (NPMI) to mine biomedical literature for gene sets associated with disease: use case in breast carcinogenesis.Comput Toxicol. 2018 Aug;7:46-57. doi: 10.1016/j.comtox.2018.06.003. Epub 2018 Jun 19. Comput Toxicol. 2018. PMID: 32274464 Free PMC article.
Biomonitoring of Metals in Children Living in an Urban Area and Close to Waste Incinerators.Int J Environ Res Public Health. 2020 Mar 16;17(6):1919. doi: 10.3390/ijerph17061919. Int J Environ Res Public Health. 2020. PMID: 32187971 Free PMC article.
Application of the Key Characteristics of Carcinogens to Per and Polyfluoroalkyl Substances.Int J Environ Res Public Health. 2020 Mar 4;17(5):1668. doi: 10.3390/ijerph17051668. Int J Environ Res Public Health. 2020. PMID: 32143379 Free PMC article. Review.
An Expanded Agenda for the Primary Prevention of Breast Cancer: Charting a Course for the Future.Int J Environ Res Public Health. 2020 Jan 22;17(3):714. doi: 10.3390/ijerph17030714. Int J Environ Res Public Health. 2020. PMID: 31979073 Free PMC article.
The Promises and Challenges of Toxico-Epigenomics: Environmental Chemicals and Their Impacts on the Epigenome.Environ Health Perspect. 2020 Jan;128(1):15001. doi: 10.1289/EHP6104. Epub 2020 Jan 17. Environ Health Perspect. 2020. PMID: 31950866 Free PMC article.
- (2014) World cancer report 2014. In Wild C.P. and Stewart B.W. (eds). World Health Organization.
- Malhotra J. (2014) Molecular and genetic epidemiology of cancer in low- and medium-income countries. Ann. Glob. Health, 80, 418–425. - PubMed
- Sankpal U.T., et al. (2012) Environmental factors in causing human cancers: emphasis on tumorigenesis. Tumour Biol., 33, 1265–1274. - PubMed
- Trosko J.E., et al. (2005) The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment. Mutagenesis, 20, 81–92. - PubMed
- N01-ES35504/ES/NIEHS NIH HHS/United States
- T32 ES007126/ES/NIEHS NIH HHS/United States
- R03 DK089010/DK/NIDDK NIH HHS/United States
- KL2TR000063/TR/NCATS NIH HHS/United States
- R01-DK52825/DK/NIDDK NIH HHS/United States
- G12 RR003062/RR/NCRR NIH HHS/United States
- R01 CA184384/CA/NCI NIH HHS/United States
- MOP-115019/CAPMC/ CIHR/Canada
- G12 MD007581/MD/NIMHD NIH HHS/United States
- MR/L007215/1/MRC_/Medical Research Council/United Kingdom
- R01 CA113447/CA/NCI NIH HHS/United States
- CA163069/CA/NCI NIH HHS/United States
- P30 ES000210/ES/NIEHS NIH HHS/United States
- R13ES023276/ES/NIEHS NIH HHS/United States
- T32CA09151/CA/NCI NIH HHS/United States
- P20 GM103476/GM/NIGMS NIH HHS/United States
- R01-CA141704/CA/NCI NIH HHS/United States
- P50 CA114747/CA/NCI NIH HHS/United States
- UL1TR000039/TR/NCATS NIH HHS/United States
- HHSN27320140003C/PHS HHS/United States
- R01 CA192613/CA/NCI NIH HHS/United States
- R01 CA170378 PQ22/CA/NCI NIH HHS/United States
- U54 MD007586/MD/NIMHD NIH HHS/United States
- R01-CA150214/CA/NCI NIH HHS/United States
- CA92306/CA/NCI NIH HHS/United States
- K01 DK075386/DK/NIDDK NIH HHS/United States
- T32 CA009151/CA/NCI NIH HHS/United States
- R01 CA92306-S1/CA/NCI NIH HHS/United States
- U54 CA151459/CA/NCI NIH HHS/United States
- R21 CA169964/CA/NCI NIH HHS/United States
- G12 MD007590/MD/NIMHD NIH HHS/United States
- ES016893/ES/NIEHS NIH HHS/United States
- CA116812/CA/NCI NIH HHS/United States
- CRUK_/Cancer Research UK/United Kingdom
- T32 CA009686/CA/NCI NIH HHS/United States
- U54 MD007593/MD/NIMHD NIH HHS/United States
- MD007593/MD/NIMHD NIH HHS/United States
- P30 CA016058/CA/NCI NIH HHS/United States
- R01 DK105118/DK/NIDDK NIH HHS/United States
- R01-ES022968/ES/NIEHS NIH HHS/United States
- U54 CA149145/CA/NCI NIH HHS/United States
- MD004038/MD/NIMHD NIH HHS/United States
- G12MD007581/MD/NIMHD NIH HHS/United States
- R01 ES016893/ES/NIEHS NIH HHS/United States
- R01-CA61774/CA/NCI NIH HHS/United States
- R01 CA092306/CA/NCI NIH HHS/United States
- SC1CA153326/CA/NCI NIH HHS/United States
- R13 ES023276/ES/NIEHS NIH HHS/United States
- R01 CA118374/CA/NCI NIH HHS/United States